MyAverix Finance
SHG · Healthcare
Beijing Hotgen Biotech Co Ltd (688068)
Biotechnology
Beijing Hotgen Biotech Co Ltd (688068) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $12.25B, P/E ratio is 18.00, net margin is -51.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 688068
Beijing Hotgen Biotech Co Ltd (688068) — FAQ
What is Beijing Hotgen Biotech Co Ltd's market cap?
Beijing Hotgen Biotech Co Ltd (688068) has a reported market cap of $12.25B (data as of 2026-03-29).
What is 688068's P/E ratio?
The price-to-earnings (P/E) ratio for Beijing Hotgen Biotech Co Ltd (688068) is 18.00 (data as of 2026-03-29).
Does Beijing Hotgen Biotech Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Beijing Hotgen Biotech Co Ltd (688068). Check the MyAverix Finance app for the latest dividend data.
What sector is Beijing Hotgen Biotech Co Ltd in?
Beijing Hotgen Biotech Co Ltd (688068) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 688068 listed on?
688068 is listed on SHG.
What is Beijing Hotgen Biotech Co Ltd's net margin?
Beijing Hotgen Biotech Co Ltd (688068) reports a net margin of -51.6% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.